Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects
Aim: About 30–40% of breast cancers lack steroid receptors (ER and/or PR) at diagnosis that worsen prognosis and limit the usage of hormone therapy. The aim of this paper has been to study the role of DNA-damaging factors as the potential modifiers of the receptor-negative tumors incidence. Material...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2006 |
| Main Authors: | Berstein, L.M., Tsyrlina, E.V., Poroshina, T.E., Levina, V.V., Vasilyev, D.A., Kovalenko, I.G., Semiglazov, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2006
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/134529 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects / L.M. Berstein, E.V. Tsyrlina, T.E. Poroshina, V.V. Levina, D.A. Vasilyev, I.G. Kovalenko, V.F. Semiglazov // Experimental Oncology. — 2006. — Т. 28, № 1. — С. 64-69. — Бібліогр.: 32 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
-
Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
by: Buchynska, L.G., et al.
Published: (2009) -
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
by: Lyalkin, S.A., et al.
Published: (2023) -
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
by: Chekhun, V.F., et al.
Published: (2009) -
Cytochrome P450, estrogen metabolites and superoxide radicals in breast cancer initiation and progression
by: A. P. Burlaka, et al.
Published: (2020) -
Clinical significance of estrogen receptor gene ERS1 SNP in cancer patients from families with oncological pathology in pedigrees
by: Paliychuk, O.V, et al.
Published: (2016)